{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:46:25Z","timestamp":1787010385508,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Raizman Haney Endowment, Hillman Foundation, Szalay Family Foundation."}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>\n                      Cytomegalovirus (CMV) antiviral drugs can cause side effects and promote the emergence of drug-resistance after transplantation. T cell\u2013mediated immunity to CMV (CMI) can be used to limit and optimize the duration of antiviral therapy. However, interferon-gamma release assays show varying rates of CMI in CMV-seronegative recipients (R\n                      <jats:sup>\u2013<\/jats:sup>\n                      ), who are at the highest risk of CMV infection with CMV-seropositive donors (D\n                      <jats:sup>+<\/jats:sup>\n                      ). Here, we characterize CMI with CMV-specific T cells that express CD154 in R\n                      <jats:sup>\u2013<\/jats:sup>\n                      liver transplant and intestine transplant recipients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>\n                      Pretransplant blood leukocyte samples from 42 R\n                      <jats:sup>\u2013<\/jats:sup>\n                      recipients were stimulated with a 15-mer overlapping peptide mixture representing the pp65 CMV antigen. CMI was measured by flow cytometry with CMV-specific CD154\n                      <jats:sup>+<\/jats:sup>\n                      T-cell frequencies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Recipients, median age (range) 3.3 (0.4\u201336.5 y), included 39 liver transplant and 3 intestine transplant. CMV serostatus was D\n                      <jats:sup>+<\/jats:sup>\n                      \/R\n                      <jats:sup>\u2013<\/jats:sup>\n                      in 21, and D\n                      <jats:sup>\u2013<\/jats:sup>\n                      \/R\n                      <jats:sup>\u2013<\/jats:sup>\n                      in 21. Protective CMI levels of &gt;1.7% previously established in 142 liver or intestine recipients were observed in 25 of 42 total R\n                      <jats:sup>\u2013<\/jats:sup>\n                      recipients (60%), including 11 of 21 D\n                      <jats:sup>+<\/jats:sup>\n                      \/R\n                      <jats:sup>\u2013<\/jats:sup>\n                      (52%) and 14 of 21 D\n                      <jats:sup>\u2013<\/jats:sup>\n                      \/R\n                      <jats:sup>\u2013<\/jats:sup>\n                      (67%) participants. CMV DNAemia was observed in the first 60 d after transplantation in 10 of 42 (24%) R\n                      <jats:sup>\u2013<\/jats:sup>\n                      recipients, including 8 of 17 with CMI &lt;1.7% and 2 of 25 with CMI &gt;1.7%. Adjusted for D\n                      <jats:sup>+<\/jats:sup>\n                      \/R\n                      <jats:sup>\u2013<\/jats:sup>\n                      , CMI&lt;1.7% was independently associated with a higher risk of DNAemia (hazard ratio 6.04 [1.2-29.4],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.026).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>CMV-specific T cells that express CD154 demonstrate protective levels of CMI in half of all seronegative recipients and can be used to optimize antiviral prophylaxis across all risk categories.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/txd.0000000000001923","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T23:04:12Z","timestamp":1771887852000},"page":"e1923","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Cytomegalovirus-specific CD154-expressing T Cells are Present Before Transplantation in Cytomegalovirus-seronegative Recipients and Predict Early Cytomegalovirus DNAemia"],"prefix":"10.1097","volume":"12","author":[{"given":"Lisa","family":"Remaley","sequence":"first","affiliation":[{"name":"Department of Surgery, School of Medicine, Hillman Center for Pediatric Transplantation, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Soltys","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Hillman Center for Pediatric Transplantation, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Fazzolare","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Hillman Center for Pediatric Transplantation, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mylarappa","family":"Ningappa","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Hillman Center for Pediatric Transplantation, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Hillman Center for Pediatric Transplantation, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Michaels","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Hillman Center for Pediatric Transplantation, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Paul","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Hillman Center for Pediatric Transplantation, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"Spishock","sequence":"additional","affiliation":[{"name":"Plexision, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Wilkerson","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Hillman Center for Pediatric Transplantation, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Raghu","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Hillman Center for Pediatric Transplantation, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon W","family":"Higgs","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Hillman Center for Pediatric Transplantation, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mazariegos","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Hillman Center for Pediatric Transplantation, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Khanna","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Hillman Center for Pediatric Transplantation, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Ganoza","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Hillman Center for Pediatric Transplantation, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Bond","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Hillman Center for Pediatric Transplantation, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chethan","family":"Ashokkumar","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Hillman Center for Pediatric Transplantation, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Sindhi","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, Hillman Center for Pediatric Transplantation, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"R1-20260223","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/TP.0000000000004352","article-title":"Increasing proportion of high-risk cytomegalovirus donor-positive\/recipient-negative serostatus in solid organ transplant recipients.","volume":"107","author":"Imlay","year":"2023","journal-title":"Transplantation"},{"key":"R2-20260223","doi-asserted-by":"crossref","first-page":"e12732","DOI":"10.1111\/tid.12732","article-title":"Burden of cytomegalovirus disease in solid organ transplant recipients: a national matched cohort study in an inpatient setting.","volume":"19","author":"Hakimi","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"R3-20260223","doi-asserted-by":"crossref","first-page":"102188","DOI":"10.1016\/j.trim.2025.102188","article-title":"CMV management of patients with leukopenia after CMV high-risk kidney transplantation.","volume":"89","author":"Abu-Omar","year":"2025","journal-title":"Transpl Immunol"},{"key":"R4-20260223","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-6143.2011.03764.x","article-title":"Prophylaxis, preemption and drug resistance in CMV infection: too little, too much or just right?","volume":"12","author":"Fishman","year":"2012","journal-title":"Am J Transplant"},{"key":"R5-20260223","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/TP.0b013e31821fad25","article-title":"Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.","volume":"92","author":"Myhre","year":"2011","journal-title":"Transplantation"},{"key":"R6-20260223","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1600-6143.2011.03766.x","article-title":"High incidence of anticytomegalovirus drug resistance among D+R- kidney transplant recipients receiving preemptive therapy.","volume":"12","author":"Couzi","year":"2012","journal-title":"Am J Transplant"},{"key":"R7-20260223","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/TP.0000000000005374","article-title":"The fourth international consensus guidelines on the management of cytomegalovirus in solid organ transplantation.","volume":"109","author":"Kotton","year":"2025","journal-title":"Transplantation"},{"key":"R8-20260223","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/TP.0000000000005173","article-title":"Cell-mediated immunity to guide primary prophylaxis for CMV infection in organ transplant recipients: a multicenter single-arm prospective study.","volume":"109","author":"Solera","year":"2025","journal-title":"Transplantation"},{"key":"R9-20260223","doi-asserted-by":"crossref","first-page":"e13601","DOI":"10.1111\/petr.13601","article-title":"CD154-expressing CMV-specific T cells associate with freedom from DNAemia and may be protective in seronegative recipients after liver or intestine transplantation.","volume":"24","author":"Ashokkumar","year":"2020","journal-title":"Pediatr Transplant"},{"key":"R10-20260223","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1600-6143.2009.02618.x","article-title":"Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients.","volume":"9","author":"Kumar","year":"2009","journal-title":"Am J Transplant"},{"key":"R11-20260223","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.transproceed.2019.11.002","article-title":"Monitoring of CMV-specific cell-mediated immunity in kidney transplant recipients with a high risk of CMV disease (D+\/R-): a case series.","volume":"52","author":"Andreani","year":"2020","journal-title":"Transplant Proc"},{"key":"R12-20260223","doi-asserted-by":"crossref","first-page":"e14294","DOI":"10.1111\/ctr.14294","article-title":"Association of CMV-specific T-cell immunity and risk of CMV infection in lung transplant recipients.","volume":"35","author":"Veit","year":"2021","journal-title":"Clin Transplant"},{"key":"R13-20260223","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1097\/TP.0000000000001825","article-title":"CMV-specific T cell monitoring offers superior risk stratification of CMV-seronegative kidney transplant recipients of a CMV-seropositive donor.","volume":"101","author":"Schachtner","year":"2017","journal-title":"Transplantation"},{"key":"R14-20260223","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/cid\/ciu589","article-title":"Preformed frequencies of cytomegalovirus (CMV)-specific memory T and B cells identify protected CMV-sensitized individuals among seronegative kidney transplant recipients.","volume":"59","author":"L\u00facia","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R15-20260223","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/ajt.12256","article-title":"Pretransplant immediately early-1-specific T cell responses provide protection for CMV infection after kidney transplantation.","volume":"13","author":"Bestard","year":"2013","journal-title":"Am J Transplant"},{"key":"R16-20260223","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3389\/fimmu.2017.01137","article-title":"Protective cytomegalovirus (CMV)-specific T-cell immunity is frequent in kidney transplant patients without serum anti-CMV antibodies.","volume":"8","author":"Litjens","year":"2017","journal-title":"Front Immunol"},{"key":"R17-20260223","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/s41591-019-0441-3","article-title":"IFN-\u03b3-independent immune markers of Mycobacterium tuberculosis exposure.","volume":"25","author":"Lu","year":"2019","journal-title":"Nat Med"},{"key":"R18-20260223","doi-asserted-by":"crossref","first-page":"105623","DOI":"10.1016\/j.antiviral.2023.105623","article-title":"Prevalence of cytomegalovirus antiviral drug resistance in transplant recipients.","volume":"215","author":"Kleiboeker","year":"2023","journal-title":"Antiviral Res"},{"key":"R19-20260223","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1111\/bjh.70136","article-title":"Adoptive transfer of third-party donor CMV-specific T cells for refractory cytomegalovirus infection following umbilical cord blood transplantation.","volume":"207","author":"Sun","year":"2025","journal-title":"Br J Haematol"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T23:04:18Z","timestamp":1771887858000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001923","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"2025-09-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}